Bio-techne Corporation (NASDAQ:TECH)

CAPS Rating: 5 out of 5

The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.

Recs

0
Player Avatar marsuculix (22.74) Submitted: 1/16/2013 2:50:43 PM : Outperform Start Price: $69.18 TECH Score: -14.09

solid business model - healthy fundamentals

Featured Broker Partners


Advertisement